MicroRNA expression profiling of megakaryocytes in primary myelofibrosis and essential thrombocythemia
- PMID: 19811223
- DOI: 10.1080/09537100903114537
MicroRNA expression profiling of megakaryocytes in primary myelofibrosis and essential thrombocythemia
Abstract
In primary myelofibrosis (PMF) and essential thrombocythemia (ET) the megakaryocytic lineage characteristically shows aberrant proliferation and maturation in which the regulatory microRNA (miR) system might be involved. Laser-microdissected PMF and ET megakaryocytes were analysed with real-time polymerase chain reaction (PCR) low density arrays comprising 365 microRNAs. The highest megakaryocytic expression levels were observed for miR-223, which is known to be expressed also in granulopoiesis. Cluster analysis revealed a tendency of disease-specific megakaryocytic microRNA expression profiles indicating that a complex shift of microRNA expression appears to be the underlying defect. Increased accumulation of miR-146b was observed in cellular stage PMF (p = 0.0125) but not ET megakaryopoiesis. In conclusion, this is the first microRNA profiling of in situ-derived PMF, ET and normal megakaryocytes.
Similar articles
-
Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.Blood. 1999 Jan 1;93(1):125-39. Blood. 1999. PMID: 9864154
-
Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.Ann Hematol. 2011 Jan;90(1):33-40. doi: 10.1007/s00277-010-1024-z. Epub 2010 Jul 13. Ann Hematol. 2011. PMID: 20625903
-
[Immunohistochemical method of megakaryocytic lineage staining in bone marrow biopsy specimens as an additional pathomorphological differential diagnostic sign of primary myelofibrosis and essential thrombocythemia].Arkh Patol. 2025;87(1):22-27. doi: 10.17116/patol20258701122. Arkh Patol. 2025. PMID: 39943725 Russian.
-
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.Neth J Med. 1999 Feb;54(2):46-62. doi: 10.1016/s0300-2977(98)00143-0. Neth J Med. 1999. PMID: 10079679 Review.
-
Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia.Neth J Med. 1997 Aug;51(2):57-64. doi: 10.1016/s0300-2977(97)00018-1. Neth J Med. 1997. PMID: 9286142 Review.
Cited by
-
Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.Am J Pathol. 2017 Jul;187(7):1512-1522. doi: 10.1016/j.ajpath.2017.03.009. Epub 2017 May 11. Am J Pathol. 2017. PMID: 28502479 Free PMC article.
-
Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study.Cardiovasc Diabetol. 2022 May 20;21(1):79. doi: 10.1186/s12933-022-01517-5. Cardiovasc Diabetol. 2022. PMID: 35596173 Free PMC article. Clinical Trial.
-
α-Hemoglobin-stabilizing protein is a sensitive and specific marker of erythroid precursors.Am J Surg Pathol. 2012 Oct;36(10):1538-47. doi: 10.1097/PAS.0b013e31825fa501. Am J Surg Pathol. 2012. PMID: 22982896 Free PMC article.
-
Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis.Leukemia. 2017 Jul;31(7):1540-1546. doi: 10.1038/leu.2017.73. Epub 2017 Feb 27. Leukemia. 2017. PMID: 28239144
-
The miRNA Profile of Platelets Stored in a Blood Bank and Its Relation to Cellular Damage from Storage.PLoS One. 2015 Jun 29;10(6):e0129399. doi: 10.1371/journal.pone.0129399. eCollection 2015. PLoS One. 2015. PMID: 26121269 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources